SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials | Zendy

Robert Puckrin | Zendy; MariePhilippe Saltiel | Zendy; Pascal Reynier | Zendy; Laurent Azoulay | Zendy; Oriana Hoi Yun Yu | Zendy; Kristian B. Filion | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials

Author(s) -

Robert Puckrin,

MariePhilippe Saltiel,

Pascal Reynier,

Laurent Azoulay,

Oriana Hoi Yun Yu,

Kristian B. Filion

Publication year - 2018

Publication title -

acta diabetologica

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.141

H-Index - 67

eISSN - 1432-5233

pISSN - 0940-5429

DOI - 10.1007/s00592-018-1116-0

Subject(s) - meta analysis , randomized controlled trial , medicine , systematic review , intensive care medicine , diabetes mellitus , medline , biology , endocrinology , biochemistry

There is concern about the infection-related safety profile of sodium-glucose co-transporter 2 (SGLT-2) inhibitors. We aimed to determine the effect of SGLT-2 inhibitors on genitourinary and other infections via systematic review and meta-analysis of randomized controlled trials (RCTs).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research